Publication | Closed Access

CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies

Cell TherapyTransplantationMarrow TransplantationHigh-risk Hematologic MalignanciesGraft-versus-host Disease ProphylaxisStem Cell TransplantationImmunologyHematologyCell TransplantationBlood TransplantationImmunotherapyMedicineCell BiologyGraft Rejection